Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Teva

Deckers Outdoor Shares Jump After Solid Q4 Results

Deckers Outdoor Corp (NYSE:DECK) reported fourth-quarter net sales growth of 31.2% year-over-year to $736 million, +31.7% on a constant currency basis, beating the consensus of $639.20 million. Wholesale net sales increased 37.6% Y/Y to $448.8 million, and Direct-to-Consumer increased 22.2% Y/Y to $287.2 million. Comparable DTC net sales increased 19.3% Y/Y. Sales…

Benzinga

Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced new study findings based on newly established clinical thresholds on short-acting beta-agonist (SABA) use and real-world usage of ProAir Digihaler (albuterol sulfate) inhalation powder. ProAir Digihaler is a breath-actuated, digital SABA inhaler with built-in flow sensors that detect, record, and store objective data. 89% (319/359) of patients…

Benzinga

Teva Pharmaceutical Industries: Why Investors Should Buy the Dip

Shares of Teva Pharmaceutical (TEVA) have plunged in price due to the company’s weak financials and its reduction of its top-line guidance. However, can the stock rebound by the company leveraging its broad product and services portfolio? Read on. Let’s find out.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

4 Analysts Have This to Say About Teva Pharmaceutical Indus

Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and AbbVie Inc's (NYSE:ABBV) Allergan Plc are willing to pay more than $5 billion combined to resolve more than 3,500 lawsuits filed over highly addictive opioid painkillers, according to three people familiar with settlement talks. The people said the companies have been in mediation talks with plaintiffs for more than a year. …

Benzinga

Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise

Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) Q1 sales reached $3.66 billion, shrinking 8% Y/Y, missing the consensus of $3.75 billion. The decrease is mainly due to lower revenues from generic products in North America and Copaxone, partially offset by higher revenues from Anda and generic products in the Europe segment. The adjusted gross…

Benzinga

Could Teva Join J&J, McKesson And Others In Settling Opioid Claims?

Teva Pharmaceutical could wrap up most of its opioid claims this year, an analyst said Tuesday as Teva stock climbed higher.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Recap: Teva Pharmaceutical Q1 Earnings

Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Benzinga

The 10 best hiking sandals that won’t break while you’re backpacking

It's time to ditch the flip-flops and buy a pair of sandals that can survive surf, sand, mud, and more.

Input

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

FDA Rejects Teva - MedinCell's Schizophrenia Candidate

Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) U.S. affiliate and MedinCell SA (OTC:MDCLF) have received FDA Complete Response Letter (CRL) regarding TV-46000/mdc-IRM for schizophrenia. The drug candidate is risperidone extended-release injectable suspension for subcutaneous use. Teva is reviewing its next steps based on the letter and will work closely with FDA to address their recommendations. Related: Teva Reports…

Benzinga

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

The Independent UK

Stock Market Lower As Benchmark Yield Jumps; This IBD 50 Stock Triggers Sell Signal

A few tech stocks are flashing sell signals.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters

West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE:

Benzinga

CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report

Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic.

The Independent UK

Florida secures $860M from CVS, others to settle opioid case

The CVS drug store company and pharmaceutical companies will pay Florida a combined $860 million as part of the settlement of an opioid epidemic case

Benzinga

Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters

Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Rhode Island's Opioid Trial Against Teva Begins Today: Reuters

The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) alleged responsibility for the opioid crisis begins jury selection Monday. The case begins over whether Teva contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades. Rhode Island says Teva created a…

Benzinga

Why Are Teva Pharmaceutical Shares Trading Higher Today?

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)

Investors Business Daily

The Struggles Continue For Generic Drug Behemoth Teva Pharmaceutical

Fourth-quarter sales of Teva Pharmaceutical's generic drugs toppled, but shares popped Wednesday on stronger-than-expected profit.

Benzinga

Teva, Texas Enter $225M Opioid Settlement Agreement

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.